Cannabis-focused research and development company The Green
Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) was welcomed this
morning by OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets
for 10,000 U.S. and global securities, as the company has qualified to trade on
the OTCQX® Best Market. The company starts trading today on OTCQX under the
symbol “TGODF.”
In addition, the company this morning announced that it has
entered into a strategic partnership with Epican Medicinals Ltd. The
partnership will add an additional 14,000 kgs to TGOD’s organic funded
capacity, bringing the total to 130,000 kgs. The companies intend to construct
a 125,000 sq. ft. GMP compliant cultivation facility. Upon receiving a site
license, the new facility and Epican’s primary Blue Mountain facility will
cultivate high premium organic strains. Per the agreement, TGOD has entered into
a binding agreement to invest into Epican for a 49.18% interest, subject to
customary regulatory and TSX approvals. TGOD will also provide Epican access to
its financing facilities to support future growth requirements.
“This represents the first of many strategic partnerships
TGOD intends to execute in the coming months,” The Green Organic Dutchman CEO
Robert Anderson stated in the news release. “Our value-added approach taken in
this investment will set an international M&A framework for capital investment,
transfer of knowledge, and sector expertise. We will continue to evaluate
international opportunities that will assist us in executing our business plan
to become the world’s largest organic cannabis brand.”
About the Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. is a research &
development company licensed under the Access to Cannabis for Medical Purposes
Regulations (“ACMPR”) to cultivate medical cannabis. The company carries out
its principal activities producing cannabis from its facilities in Ancaster,
Ont., pursuant to the provisions of the ACMPR and the Controlled Drugs and
Substances Act (Canada) and its regulations. The company grows high quality,
organic cannabis with sustainable, all-natural principles. TGOD’s products are
laboratory tested to ensure patients have access to a standardized, safe and
consistent product. TGOD has a funded capacity of 116,000 kg and is building
970,000 sq. ft. of cultivation facilities in Ontario and Quebec. The company
has developed a strategic partnership with Aurora Cannabis Inc. (TSX: ACB)
whereby Aurora has invested approximately C$78.1 million for an approximate
17.5% stake in TGOD. In addition, the company has raised approximately C$315
million dollars and has over 5,000 shareholders. TGOD’s Common Shares and
warrants issued under the indenture dated November 1, 2017 trade on the TSX
under the symbol “TGOD” and “TGOD.WT”, respectively. For more information,
visit the company’s website at www.TGOD.ca.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
